Hyperkalemia: Getting to the heart of the matter

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 15-16

  Welch, Amanda ^a,b   Maroz, Natallia ^a,b   Wingo, Charles S ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; POTASSIUM;

CHRONIC KIDNEY DISEASE; ELECTROCARDIOGRAPHY; HEART CONDUCTION; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; NOTE; POTASSIUM BLOOD LEVEL; PR INTERVAL; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; R WAVE; T WAVE;

ARRHYTHMIAS, CARDIAC; FEMALE; HUMANS; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; POTASSIUM;

EID: 84872221461     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs403     Document Type: Note

References (3)

1. Sacchetti A, Stuccio N, Panebianco P et al. Hemodialysis for treatment of renal failure emergencies. J Emerg Med 1999; 17: 305-307.
2. El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J 2011; 18: 233-245
3. Green D, New D, Kalra P. The clinical significance of hyperkalaemiaassociated repolarisation abnormalities in end-stage renal disease. Nephrol Dial Transplant 2013; 28: 99-105.